False homozygous deletions of SMN1 exon 7 using Dra I PCR-RFLP caused by a novel mutation in spinal muscular atrophy

Genet Test Mol Biomarkers. 2009 Aug;13(4):511-3. doi: 10.1089/gtmb.2008.0158.

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder, and about 95% of SMA patients are homozygous for deletions in the SMN1 gene. Herein, classical polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) using DraI yielded false homozygous deletions of SMN1 exon 7 in a patient with SMA, but multiple ligation-dependent probe amplification analysis revealed one remaining copy of SMN1 exon 7. Sequencing showed that this false deletion in the PCR-RFLP resulted from a novel mutation of one SMN1 copy that was not deleted (c.863G > T, p.R288M). This novel sequence variant introduced a mismatch that interfered with primer binding. These findings demonstrate that comprehensive analysis using PCR-RFLP, multiple ligation-dependent probe amplification, and sequencing can reliably and correctly diagnose SMA.

Publication types

  • Case Reports

MeSH terms

  • Base Sequence
  • Deoxyribonucleases, Type II Site-Specific / metabolism
  • Exons / genetics*
  • False Positive Reactions*
  • Homozygote*
  • Humans
  • Infant
  • Male
  • Molecular Sequence Data
  • Muscular Atrophy, Spinal / diagnosis*
  • Muscular Atrophy, Spinal / genetics*
  • Nucleic Acid Amplification Techniques
  • Polymerase Chain Reaction / methods
  • Polymorphism, Restriction Fragment Length
  • Sequence Analysis, DNA
  • Sequence Deletion*
  • Survival of Motor Neuron 1 Protein / genetics*

Substances

  • Survival of Motor Neuron 1 Protein
  • Deoxyribonucleases, Type II Site-Specific
  • TTTAAA -specific type II deoxyribonucleases